This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The Washington Post
washingtonpost.com
did:plc:k5nskatzhyxersjilvtnz4lh
Breaking news: The FDA reversed course and agreed to review Moderna’s application for the first mRNA-based flu vaccine under a revised approach, the company announced. In a rare move last week, the agency had declined to review the vaccine.
https://wapo.st/3MLxSCa
2026-02-18T14:10:24.653Z